Asparagine bioavailability governs metastasis in a model of breast cancer.
about
Biosynthetic energy cost for amino acids decreases in cancer evolutionInhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid responseThe "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast CancersEndogenous HIF2A reporter systems for high-throughput functional screeningCrystal structures of three halide salts of l-asparagine: an isostructural series
P2860
Asparagine bioavailability governs metastasis in a model of breast cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Asparagine bioavailability governs metastasis in a model of breast cancer.
@en
Asparagine bioavailability governs metastasis in a model of breast cancer.
@nl
type
label
Asparagine bioavailability governs metastasis in a model of breast cancer.
@en
Asparagine bioavailability governs metastasis in a model of breast cancer.
@nl
prefLabel
Asparagine bioavailability governs metastasis in a model of breast cancer.
@en
Asparagine bioavailability governs metastasis in a model of breast cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Asparagine bioavailability governs metastasis in a model of breast cancer.
@en
P2093
Ashley R Maceli
Clive S D'Santos
Evangelia K Papachristou
Gregory J Hannon
J Chuck Harrell
John E Wilkinson
Lisa A Carey
Michel Wagner
P2860
P2888
P304
P356
10.1038/NATURE25465
P407
P50
P577
2018-02-07T00:00:00Z